Synapse - Mark Kris

Results (223)

Comprehensive assessment of targetable driver alterations in lung adenocarcinomas using a clinical, hybrid capture-based, next-generation sequencing assay

Meeting Abstract

Arcila, M.; Zehir, A.; Cheng, D.; Yu, H.; Kris, M.; Drilon, A.; Riely, G.; Berger, M.; Ladanyi, M.
Laboratory Investigation (2015)

Fulltext@MSK | Save

Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium

Journal Article

Villaruz, L. C.; Socinski, M. A.; Abberbock, S.; Berry, L. D.; Johnson, B. E.; Kwiatkowski, D. J.; John Iafrate, A.; Varella-Garcia, M.; Franklin, W. A.; Camidge, D. R.; more...
Cancer (2015)

Fulltext@MSK | Save

Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival

Meeting Abstract

Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas

Meeting Abstract

Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in "pan-negative" lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history

Meeting Abstract

Drilon, A. E.; Wang, L.; Arcila, M. E.; Cho, E. J.; Balasubramanian, S.; Greenbowe, J. R.; Ross, J. S.; Stephens, P.; Lipson, D.; Miller, V. A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis program (MAP) at Memorial Sloan Kettering Cancer Center (MSKCC)